NRXN2 belongs to the neurexin family, a group of synaptic cell adhesion molecules that play key roles in regulating synaptic functions and transsynaptic signaling (Südhof, 2017); it has also been proposed as a CSF biomarker candidate for several neurological disorders. The gene discussed is CADM1; the disease is nervous system disorder.